Aurora Cannabis Inc. (ACB)

CA — Healthcare Sector
Peers: TKNO  CGC  LFCR  BIOA  IRWD  OGI  HITI  LFMD  ACRS  EDIT 

Automate Your Wheel Strategy on ACB

With Tiblio's Option Bot, you can configure your own wheel strategy including ACB - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol ACB
  • Rev/Share 6.4714
  • Book/Share 10.7799
  • PB 0.5828
  • Debt/Equity 0.1841
  • CurrentRatio 2.9659
  • ROIC 0.1006

 

  • MktCap 333233771.9275
  • FreeCF/Share -0.0182
  • PFCF -333.5673
  • PE 4.5881
  • Debt/Assets 0.1213
  • DivYield 0
  • ROE 0.1262

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 3
  • DCF Score 4
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation ACB TD Cowen -- Buy -- -- Dec. 11, 2024

News

Top Marijuana Stocks To Know In Today's Stock Market 2025
ACB, CGC, CRON
Published: March 05, 2025 by: MarijuanaStocks
Sentiment: Positive

As the cannabis industry continues to grow, more companies are expanding their product lines beyond traditional flower sales. This includes edibles, oils, and wellness products, attracting a broader consumer base. The demand for more cannabis products is helping bridge some gaps between existing players. For example, when companies partner in some way to create and release products, it often has a positive impact all the way around for the companies.

Read More
image for news Top Marijuana Stocks To Know In Today's Stock Market 2025
Is Aurora Cannabis (ACB) Stock Outpacing Its Medical Peers This Year?
ACB
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Positive

Here is how Aurora Cannabis Inc. (ACB) and AdaptHealth Corp. (AHCO) have performed compared to their sector so far this year.

Read More
image for news Is Aurora Cannabis (ACB) Stock Outpacing Its Medical Peers This Year?
Wall Street Analysts Predict a 25.67% Upside in Aurora Cannabis (ACB): Here's What You Should Know
ACB
Published: February 25, 2025 by: Zacks Investment Research
Sentiment: Positive

The mean of analysts' price targets for Aurora Cannabis (ACB) points to a 25.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Read More
image for news Wall Street Analysts Predict a 25.67% Upside in Aurora Cannabis (ACB): Here's What You Should Know
Best Value Stocks to Buy for February 21st
ACB, PRTH
Published: February 21, 2025 by: Zacks Investment Research
Sentiment: Positive

ACB, and PRTH made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 21, 2024.

Read More
image for news Best Value Stocks to Buy for February 21st
Aurora Cannabis Skyrockets After Earnings: Should You Buy Into the Rally?
ACB
Published: February 12, 2025 by: The Motley Fool
Sentiment: Positive

The year is a more than a month old, but Aurora Cannabis (ACB -2.87%) is already one of the hottest stocks to own in 2025. As of Feb. 11, the pot stock has soared more than 50% since the year began -- and that rally began only a few days ago.

Read More
image for news Aurora Cannabis Skyrockets After Earnings: Should You Buy Into the Rally?
Aurora Cannabis: Strong Buy On Blowout Results And Constructive Outlook
ACB
Published: February 09, 2025 by: Seeking Alpha
Sentiment: Positive

Last week, Aurora Cannabis reported blowout Q3/FY2025 results with sales, gross margins, profitability, and free cash flow reaching new all-time highs. As a leader in the medical cannabis space, the company is enjoying premium margins. Following the descheduling of cannabis in Germany last year, sales in Europe have increased substantially. Cash, restricted cash and cash equivalents increased to $180.2 million. The company's core cannabis operations remain debt free.

Read More
image for news Aurora Cannabis: Strong Buy On Blowout Results And Constructive Outlook

About Aurora Cannabis Inc. (ACB)

  • IPO Date 2014-07-15
  • Website https://www.auroramj.com
  • Industry Drug Manufacturers - Specialty & Generic
  • CEO Miguel Martin
  • Employees 1073

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.